The search for cancer stem cells in hepatocellular carcinoma

Surgery

Volumn 144, Issue 2, 2008, Pages 119-124

  Kamohara, Yukio ^a,b,c   Haraguchi, Naotsugu ^a,c   Mimori, Koshi ^a,c   Tanaka, Fumiaki ^a,c   Inoue, Hiroshi ^a,c   Mori, Masaki ^a,c   Kanematsu, Takashi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENIC ACTIVITY; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

ALBUMINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; G0 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; KERATIN-19; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 47549090603     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.04.008     Document Type: Article

References (31)

1. Ikai I., Arii S., Ichida T., Okita K., Omata M., Kojiro M., et al. Report of the 16th follow-up survey of primary liver cancer. The Liver Cancer Study Group of Japan. Hepatol Res 32 (2005) 163-172
2. Arii S., Yamaoka Y., Futagawa Y., Inoue K., Kobayashi K., Kojiro M., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32 (2000) 1224-1229
3. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of hepatocellular carcinomas in patient with cirrhosis. N Eng J Med 334 (1996) 693-699
4. Liovet J.M., Real M.I., Montana X., Planas R., Coll S., Aponte J., et al. Arterial embolisation or chemoembolisation versus systemic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359 (2002) 1734-1739
5. Wulf G.G., Wang R.Y., Kuehnle I., Waiden D., Marini F., Brenner M.K., et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 98 (2001) 1166-1173
6. Pardal R., Clarke M.F., and Morrison S.J. Applying the principles of stem cell biology to cancer. Nature Rev Cancer 3 (2003) 859-902
7. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-gortes J., et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 367 (1994) 645-648
8. Haraguchi N., Inoue H., Tanaka F., Mimori K., Utsunomiya T., and Mori M. Cancer stem cells in human gastrointestinal cancers. Human Cell 19 (2006) 24-29
9. Haraguchi N., Utsunomiya T., Inoue H., Tanaka F., Mimori K., Bernard G.F., et al. Characterization of side population of cancer cells from human gastrointestinal system. Stem Cells 24 (2005) 506-513
10. Suetsugu A., Nagaki M., Aoki H., Motohashi T., Kunisada T., and Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 29 (2006) 820-824
11. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., et al. Identification and characterization of tumorgenic liver cancer stem/progenitor cells. Gastroenterology 132 (2007) 2542-2546
12. Yin S., Li J., Hu C., Chen X., Yao M., Yan M., et al. CD133 positive hepatoellular carcinoma cells possess high capacity for tumorigenecity. Int J Cancer 120 (2007) 1444-1450
13. Passegue E., Wagers A.J., Giuriato S., Anderson W.C., and Weissman I.L. Global analysis of proliferation and cell cycle. J Exp Med 26 (2007) 1599-1611
14. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25 (2006) 3518-3522
15. Al-Hajj M., Wicha M.S., Bento Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100 (2003) 3983-3988
16. Natarajan T.G., and Fitzgerald T.G. Markers in normal and cancer stem cells. Cancer Biomark 3 (2007) 211-231
17. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 425 (2003) 841-846
18. Guan Y., Gerhard B., Donna E., and Hogge D.E. Detection, isolation, and stimulation of quiescent primitive leukemic progenitorcells from patients with acute myeloid leukemia (AML). Blood 101 (2003) 3142-3149
19. Chiba T., Zheng Y.-W., Kita K., Saisho H., Onodera M., Miyoshi H., et al. Enhanced self-renewal capability in hepatic stem/progenitor cell drives cancer initiation. Gastroenterology 133 (2007) 937-950
20. Yamashita T., Budhu A., Forgues M., and Wang X.W. Activation of hepatic stem cell marker EpCAM by Wnt-β-catenin signaling hepatocellular carcinoma. Cancer Res 67 (2007) 10831-10839
21. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., et al. Cancer stem cells-perspectives on current status and future directions. Cancer Res 66 (2006) 9339-9344
22. Lee J.S., Heo J., Chu I.S., Kaposi-Novac P., Calvisi D.A., Mikaelyan A., et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 12 (2006) 410-416
23. Ma S., Lee T.K., Zheng B.-J., Chan K.W., and Guan X.-Y. CD133+ cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27 (2008) 1749-1758
24. Dean M., Fojo T., and Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer 5 (2005) 275-284
25. Perez-Caro M., and Sanchez-Garcia I. Killing time for cancer stem cells (CSC): Discovery and development of selective CSC inhibitors. Curr Med Chem 13 (2006) 1719-1725
26. Jones D.L., and Wagers A.J. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol 9 (2008) 11-21
27. Nakayama K.I., and Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol 16 (2005) 323-333
28. Groszer M., Erickson R., Scripture-Adams D.D., Dougherty D.J., Le Belle J., Zack J.A., et al. PTEN negatively regulates neural stem cell self-renewal by modeling G0-G1 cell cycle entry. Proc Natl Acad Sci U S A 3 (2006) 111-116
29. Besson A., Hwang H.C., Cicero S., Donovan S.L., Gurian-West M., Johnson D., et al. Discovery of an oncogenic activity in P27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 21 (2007) 1731-1746
30. Wodarz D. Targeted cancer treatment: resisting arrest. Nature 12 (2006) 1125-1126
31. Onoyama I., Tsunematsu R., Matsumoto A., Kimura T., de Alboran I.M., Nakayama K., et al. Conditional inactivation of Fbxw7 implies cell cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 26 (2007) 2875-2888